CVS urges cost controls for new cholesterol drugs
Reuters - February 17, 2015
CVS Health warned on Tuesday that the costs of a potent new class of cholesterol treatments could eclipse those of other expensive medicines and overwhelm the U.S. healthcare system "if rigid cost control mechanisms are not put in place."
New Approach to Blocking HIV Raises Hopes for an AIDS Vaccine
New York Times - February 18, 2015
A new compound has blocked HIV infection so well in monkeys that it may be able to function as a vaccine against AIDS, the scientists who designed it reported Wednesday.
Why Are Biologic Drugs So Costly?
U.S. News & World Report - February 6, 2015
Patients find many biologics effective, but some treatments can cost more than $45,000 per year.
Chemoprevention works against breast cancer, but these drugs are not popular
Washington Post - February 16, 2015
What if there was a medication that could at least reduce a woman’s risk of developing breast cancer? Such drugs already exist.
Along with Cutting Costs and Improving Productivity, Benefits Programs Also Affecting Loyalty
WorldatWork - February 5, 2015
As companies focus on maintaining employee productivity and controlling costs when designing benefits programs, these plans also can greatly improve loyalty.
Anti-VEGF Drugs Boost Vision in Diabetic Eyes
MedPage Today - February 18, 2015
Three anti-VEGF therapies improved visual acuity in a national head-to-head trial among diabetic macular edema (DME) patients, although aflibercept (Eylea) bested bevacizumab (Avastin) and ranibizumab (Lucentis) in those who started out with worse vision, researchers found.
Door-to-door campaign linked hepatitis C patients to care
ScienceDaily - February 13, 2015
Working on the streets in medically underserved Philadelphia neighborhoods, members of the Do One Thing program have been able to identify residents chronically infected with hepatitis C and help them overcome the hurdles that prevent people from being cured, according to a new study.
Fact sheets: CMS finalizes program changes for Medicare Advantage and Prescription Drug Benefit Programs for Contract Year 2016
Centers for Medicare & Medicaid Services - February 6, 2015
CMS finalizes program changes for Medicare Advantage and Prescription Drug Benefit Programs for Contract Year 2016.
Contact,
Jan Tankersley
Senior Vice President, Marketing & Sales
Pharmaceutical Strategies Group (PSG)
Office: 972-943-7141
Email: JTankersley@PSGConsults.com
PSGNewsletter@PSGConsults.com
www.PSGConsults.com
 |
 |
 |